Research ArticleClinical Studies

Epirubicin and Cyclophosphamide Followed by Docetaxel as Primary Systemic Chemotherapy in Locally Advanced Breast Cancer

AKIRA HIRANO, TADAO SHIMIZU, OSAMU WATANABE, JUN KINOSHITA, KIYOMI KIMURA, MARI KAMIMURA, KAORU DOMOTO, MOTOHIKO AIBA and KENJI OGAWA
Anticancer Research November 2008, 28 (6B) 4137-4142;

Article Information

vol. 28 no. 6B 4137-4142
PMID 
19192673
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 3, 2008
  • Revision received August 20, 2008
  • Accepted September 8, 2008
  • Published online November 1, 2008.
Copyright & Usage 
Copyright© 2008 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. AKIRA HIRANO1,
  2. TADAO SHIMIZU1,
  3. OSAMU WATANABE1,
  4. JUN KINOSHITA1,
  5. KIYOMI KIMURA1,
  6. MARI KAMIMURA1,
  7. KAORU DOMOTO1,
  8. MOTOHIKO AIBA2 and
  9. KENJI OGAWA1
  1. 1Department of Surgery, Tokyo Women's Medical University Medical Center East, Tokyo 116-8567, Japan
  2. 2Department of Surgical Pathology, Tokyo Women's Medical University Medical Center East, Tokyo 116-8567, Japan
  1. Correspondence to: Tadao Shimizu, MD, 2-1-10 Nishiogu, Arakawa-ku, Tokyo 116-8567, Japan. Tel: +81 3 3810 1111, Fax: +81 3 3894 5493, e-mail: shimitsu{at}dnh.twmu.ac.jp

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Epirubicin and Cyclophosphamide Followed by Docetaxel as Primary Systemic Chemotherapy in Locally Advanced Breast Cancer
AKIRA HIRANO, TADAO SHIMIZU, OSAMU WATANABE, JUN KINOSHITA, KIYOMI KIMURA, MARI KAMIMURA, KAORU DOMOTO, MOTOHIKO AIBA, KENJI OGAWA
Anticancer Research Nov 2008, 28 (6B) 4137-4142;
Twitter logo Facebook logo Mendeley logo

Jump to section